SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

Manufacturer: Fischer Scientific

Select a Size

Pack Size	SKU	Availability	Price
Each of 1	LMAB10731SP-Each-of-1	In Stock	₹ 17,844.50

LMAB10731SP - Each of 1

₹ 17,844.50

In Stock

Quantity

Base Price: ₹ 17,844.50

GST (18%): ₹ 3,212.01

Total Price: ₹ 21,056.51

Antigen

Spike RBD

Classification

Monoclonal

Conjugate

Unconjugated

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.

Host Species

Llama

Purification Method

Protein A or G purified from cell culture supernatant

Regulatory Status

RUO

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Applications

Blocking Assay

Clone

L009.1.32H

Dilution

Blockade of Receptor-ligand Interaction 50 ug/mL

Gene Accession No.

YP_009724390.1

Immunogen

Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1